Vaccination series: 3 doses administered orally to infant. 1st dose: At 6-12 wk; subsequent doses should be administered at min: 4-wk interval between each dose.
Individuals w/ malignancies or immunocompromised or those receiving immunosuppressive therapy; HIV-infected; those who have received blood transfusion or products eg, Ig w/in 42 days. Acute infection or febrile illness. Infants w/ active GI illness, chronic diarrhea, growth retardation or history of congenital abdominal disorders or intussusception. Infant <6 wk.